Precision Medicine Research in the Million-Genome Era
Gaining the Most from Research with Multi-Omic Data in the Million-Genome Era
Top 10 M&A Deals of 2016
While 2016 Didn’t Reach the Heights Predicted, the Overall Value of Biopharma M&A Climbed
U.K. Bioindustry Plots Its Post-Brexit Course
Improving Manufacturing of Advanced Therapies Is One of Several Initiatives Being Put in Place
GEN Roundup: Kinase Assays from Preliminary Screens to “Smart” Deployment
GEN Interviewed Six Experts to Explore Kinase Assays
For full access to this article login to GEN Select now.
Biobanking Confronts Growing Pains
- The quest for personalized medicine adds to the complexity of today’s scientific questions. Drug discovery efforts require access to larger arrays of biosamples, and demand is exceeding supply, fueling the growth of the biobanking market. “Humans are inherently variable, which is good for evolution but bad for drug ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.